Skip to content

Cognitive Behavioral Therapy for Insomnia vs. Exposure, Relaxation, and Rescripting Therapy

CBT-I Versus ERRT: Impact on Sleep, Nightmares, and Suicidal Ideation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03831412
Enrollment
13
Registered
2019-02-05
Start date
2017-08-01
Completion date
2021-01-31
Last updated
2021-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, Nightmare, Trauma

Brief summary

The objective of this project is to determine if directly addressing disturbed sleep and nightmares will impact client reports of suicidal ideation.

Interventions

BEHAVIORALCBT-I

Targeting insomnia symptoms to reduce suicidal ideation and sleep problems related to traumatic experience.

BEHAVIORALERRT

Targeting post-trauma nightmares to reduce suicidal ideation and sleep problems related to traumatic experience.

Sponsors

University of Tulsa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* experiences at least one nightmare per week for the past month * having previously experienced a traumatic event * difficulty falling or staying asleep * suicidal ideation * actively under the care of another health care provider

Exclusion criteria

* untreated obstructive sleep apnea * acute or apparent psychosis * untreated or unstable bipolar disorder * past history of seizure disorder or neurological disorder * intellectual disability * current substance dependence or in past 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Insomnia Severity IndexFrom initial assessment to each session of treatment, and at 3 and 6 months after treatment completionChange in frequency of insomnia symptoms
Change in Sleep logFrom initial assessment to each session of treatment, and at 3 and 6 months after treatment completionChange in frequency of nightmares
Change in Beck Suicide ScaleFrom initial assessment to each session of treatment, and at 3 and 6 months after treatment completionChange in severity of suicidal ideation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026